Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
56 studies found for:    Open Studies | "Papilloma"
Show Display Options
Rank Status Study
21 Not yet recruiting HPV Screening (Human Papilloma Virus)
Condition: HPV Testing
22 Unknown  A Model for Implementation of Cervical Cancer Screening and HPV Vaccination the Emergency Department: a Pilot Study
Condition: Genital Human Papilloma Virus Infection
Intervention: Drug: Gardasil
23 Unknown  3-year Immunogenicity Evaluation of Quadrivalent HPV Vaccine in China
Condition: Anogenital Human Papilloma Virus Infection
24 Unknown  Acceptability and Feasibility of Human Papilloma Virus Vaccine
Condition: Cervical Cancer
Intervention: Behavioral: Health education
25 Not yet recruiting "Performance of HPV DNA Test in Presence of Co-infection With Common RTIs"
Condition: Cervical Inflammation and Human Papilloma Virus Performance
Intervention: Drug: Tab cefixime,Tab Azithromycin
26 Unknown  The Study of Immunogenicity of Quadrivalent Vaccine Against Human Papilloma Virus (HPV) Types 6, 11, 16, and 18 (HPV-6/11/16/18) in Chronic Kidney Disease (CKD) Patients
Conditions: Chronic Kidney Disease, Stage IV (Severe);   Chronic Kidney Disease, Stage V
Intervention: Biological: HPV-6/11/16/18 vaccine
27 Not yet recruiting Safety and Immunogenicity Study of Human Papilloma Virus Vaccine in Women Aged 9 to 30 and Men Aged 9 to 17
Condition: Cervical Cancer
Interventions: Biological: Tetravalent recombinant human papilloma virus vaccine (6,11,16,18 type) (Hansenula polymorpha);   Biological: placebo
28 Recruiting A Phase II Trial of a Protease Inhibitor, Nelfinavir (NFV), Given With Definitive, Concurrent Chemoradiotherapy (CTRT) in Patients With Locally-Advanced, Human Papilloma Virus (HPV) Negative, Squamous Cell Carcinoma Larynx
Condition: Stage III, IVa, or IVb Squamous Cell Carcinoma of the Oral Cavity, Oropharynx, Larynx, or Hypopharynx
Intervention: Drug: Nelfinavir (Viracept®) 1250 mg
29 Recruiting A Single-arm Phase II Study of Post-Transoral Robotic Surgery (TORS) Alone to the Primary Tumor Site and Selective Neck Dissection (SND) Followed by Adjuvant Radiation Therapy (+/- Chemotherapy) to the Regional Nodes for Advanced Stage, Human Papilloma Virus (HPV) Positive, Oropharyngeal Cancer
Condition: Oropharyngeal Cancer
Interventions: Procedure: TORS;   Radiation: Adjuvant Radiation Therapy
30 Recruiting HPV (Human Papilloma Virus) Vaccination After Treatment of Anal Intraepithelial Neoplasia (AIN)
Conditions: AIN;   HIV
Interventions: Biological: Gardasil;   Drug: Placebo
31 Unknown  Evaluation of ELISA Assay on Human Papilloma Viruses (HPV) Infection Population
Conditions: Patient With Invasive Cervical Carcinoma;   Patient With CIN Lesion;   Patient With HPV Infected Patients Without Histopathologic Lesion;   Normal Populations.
Intervention: Procedure: peripheral blood isolation
32 Not yet recruiting Effectiveness Study of Human Papilloma Virus (HPV) Vaccines to Prevent Recurrence of Genital Warts
Condition: Genital Warts
Interventions: Biological: Quadrivalent HPV vaccine;   Biological: Hepatitis B vaccine
33 Unknown  DNA Analysis of Tumor Tissue Samples From Patients With Human Papilloma Virus-Associated Cancer of the Oropharynx
Condition: Head and Neck Cancer
Interventions: Genetic: gene expression analysis;   Genetic: mutation analysis;   Genetic: polyacrylamide gel electrophoresis;   Genetic: polymerase chain reaction;   Genetic: protein expression analysis;   Genetic: reverse transcriptase-polymerase chain reaction;   Other: flow cytometry;   Other: immunoenzyme technique;   Other: immunologic technique;   Other: laboratory biomarker analysis;   Other: pharmacological study
34 Recruiting Recombinant Human Papillomavirus Nonavalent Vaccine in Preventing Human Papilloma Virus in Younger Healthy Participants
Conditions: Human Papillomavirus Infection;   No Evidence of Disease
Interventions: Other: Laboratory Biomarker Analysis;   Biological: Recombinant Human Papillomavirus Nonavalent Vaccine
35 Not yet recruiting Safety Study of EF-022 in Adults With Recurrent Respiratory Papillomatosis (RRP)
Condition: Recurrent Respiratory Papillomatosis
Intervention: Drug: EF-022 (Modified Vitamin D Binding Protein Macrophage Activator)
36 Recruiting Recurrent Respiratory Papillomatosis and Extraesophageal Reflux
Conditions: Recurrent Respiratory Papillomatosis;   Extra Oesophageal Reflux;   Laryngeal Cyst
Interventions: Procedure: Surgical collection of histology specimen;   Procedure: Performance of immunohistochemical analysis
37 Recruiting Bevacizumab Versus Cidofovir for the Treatment of Recurrent Respiratory Papillomatosis
Condition: Recurrent Respiratory Papillomatosis
Interventions: Drug: Bevacizumab;   Drug: Cidofovir;   Other: Placebo
38 Not yet recruiting 4-valent HPV Vaccine to Treat Recurrent Respiratory Papillomatosis in Children
Condition: Recurrent Respiratory Papillomatosis
Intervention: Biological: 4-valent HPV vaccine
39 Recruiting Reduced-intensity Therapy for Oropharyngeal Cancer in Non-smoking HPV-16 Positive Patients
Conditions: Squamous Cell Carcinoma of the Oropharynx;   HPV
Interventions: Drug: Cetuximab;   Radiation: Radiotherapy
40 Recruiting Image-Guided Stereotactic Radiosurgery (SRS) Boost for HPV-Oropharyngeal Cancer
Condition: Cancer of the Oropharynx
Intervention: Radiation: Stereotactic Radiosurgery

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-56) Show next page of results    Last Page
Indicates status has not been verified in more than two years